Genetic Evidence for Causal Effects of Blood Metabolites on Age-Related Macular Degeneration and its Subtypes

Read full text Summarise with VIRAT
Authors: Keting Zhang, Lanbo Jia, Chunbing Zhao, Yining Wang, Pinghui Wei, Guoge Han
Cited by: 0
References: 92

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Purpose: Age-related macular degeneration (AMD) is a predominant cause of permanent vision impairment among older individuals. Despite available treatments for advanced disease, a comprehensive understanding of the pathogenesis, specifically the pivotal causal pathways, remains elusive. This study aims to assess the causal effects of 1400 serum metabolites and their ratios on 3 AMD subtypes using Mendelian randomization (MR). Methods: This study leveraged an integrated MR analytical framework to systematically investigate the causal relationships of 1400 circulating metabolites and metabolite ratios with 3 AMD subtypes: early, dry, and wet AMD. The robustness and consistency of the findings were validated via comprehensive sensitivity analyses, alongside assessments for heterogeneity and horizontal pleiotropy. Results: Of the 1400 metabolites and metabolite ratios examined, inverse variance weighting identified 77, 62, and 80 metabolites with statistically significant causal associations with early, dry, wet AMD, respectively. Most of these associations demonstrated consistency across complementary MR methodologies. Furthermore, most of the identified metabolites did not show significant evidence of heterogeneity or horizontal pleiotropy. Notably, among lipid classes, glycerophosphoethanolamine (GPE) metabolites consistently exhibited protective effects. Conclusions: Multiple metabolite classes, including glycerophospholipids, fatty acids, steroid hormones, and energy metabolism intermediates, are involved in AMD pathogenesis. These findings confirm that metabolic dysregulation is the principal driver of AMD at the causal level, in addition to revealing heterogeneous effect sizes of distinct metabolic pathways across disease subtypes. This study reveals potential molecular targets for developing strategies based on metabolism for AMD prevention, diagnosis, and precision therapeutics. Translational Relevance: This work bridges fundamental metabolic discoveries to clinical application by identifying causal metabolites as novel therapeutic targets and informing strategies specific to disease subtypes for precision medicine and diagnostics in AMD.

Fields of Study & Subjects

Retinal Diseases and Treatments Metabolomics and Mass Spectrometry Studies Retinal Imaging and Analysis

Publication details

Journal / source
Translational Vision Science & Technology
Volume
15
Issue
3
Pages
31–31
Publication date
26 March 2026
Language
EN